Rx abuse monitoring law
President Bush signs the "National All Schedules Prescription Electronic Reporting Act" into law Aug. 11. The law, which passed the House July 27 and the Senate July 29, authorizes $60 mil. over fiscal years 2006-2010 for states to create or augment monitoring systems to track prescriptions of Schedule II-IV drugs across state lines (1"The Pink Sheet" Aug. 8, 2005, p. 27). The monitoring programs will require healthcare providers to report the dispensation of controlled substances within a week. Following a public comment period, the Secretary of HHS will establish minimum requirements, including certain privacy provisions, that states must meet in order to be eligible for grants under the law...
You may also be interested in...
Pharmaceutical importation prohibitions in future U.S. trade agreements would be forbidden under a bill co-sponsored by Sens. David Vitter (R-La.) and Debbie Stabenow (D-Mich.)
Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.
Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials.